Conference Proceedings

Patients' preferences for 3 months versus 6 months of adjuvant chemotherapy (ACT) for colon cancer in the SCOT trial: what survival benefits make longer chemotherapy worthwhile?

Prunella Louise Blinman, Andrew James Martin, Michael Jefford, David Goldstein, David Boadle, Michelle Frances Morris, Niall C Tebbutt, Christine Aiken, James Paul, Eva Segelov, Andrew Mark Haydon, Tim Iveson, Martin R Stockler

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2018